0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Pancreas Devices Systems Market Research Report 2026
Published Date: 2026-01-16
|
Report Code: QYRE-Auto-29D8786
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Artificial Pancreas Devices Systems Market Outlook 2022
BUY CHAPTERS

Global Artificial Pancreas Devices Systems Market Research Report 2026

Code: QYRE-Auto-29D8786
Report
2026-01-16
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artificial Pancreas Devices Systems Market Size

The global Artificial Pancreas Devices Systems market was valued at US$ 124 million in 2025 and is anticipated to reach US$ 272 million by 2032, at a CAGR of 12.1% from 2026 to 2032.

Artificial Pancreas Devices Systems Market

Artificial Pancreas Devices Systems Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Artificial Pancreas Devices Systems competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report delivers a comprehensive overview of the global Artificial Pancreas Devices Systems market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artificial Pancreas Devices Systems. The Artificial Pancreas Devices Systems market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Artificial Pancreas Devices Systems market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Artificial Pancreas Devices Systems manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Artificial Pancreas Devices Systems Market Report

Report Metric Details
Report Name Artificial Pancreas Devices Systems Market
Accounted market size in 2025 US$ 124 million
Forecasted market size in 2032 US$ 272 million
CAGR 12.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Threshold Suspended Device Systems
  • Hybrid Closed-loop APDS
  • Other Systems
by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Artificial Pancreas Devices Systems manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Artificial Pancreas Devices Systems sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Artificial Pancreas Devices Systems Market growing?

Ans: The Artificial Pancreas Devices Systems Market witnessing a CAGR of 12.1% during the forecast period 2026-2032.

What is the Artificial Pancreas Devices Systems Market size in 2032?

Ans: The Artificial Pancreas Devices Systems Market size in 2032 will be US$ 272 million.

What is the Medtronic share in Artificial Pancreas Devices Systems Market?

Ans: Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.

What is the Artificial Pancreas Devices Systems Market share by region?

Ans: North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.

What is the Artificial Pancreas Devices Systems Market share by type?

Ans: In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%.

Who are the main players in the Artificial Pancreas Devices Systems Market report?

Ans: The main players in the Artificial Pancreas Devices Systems Market are Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed

What are the Application segmentation covered in the Artificial Pancreas Devices Systems Market report?

Ans: The Applications covered in the Artificial Pancreas Devices Systems Market report are Hospitals, Clinics

What are the Type segmentation covered in the Artificial Pancreas Devices Systems Market report?

Ans: The Types covered in the Artificial Pancreas Devices Systems Market report are Threshold Suspended Device Systems, Hybrid Closed-loop APDS, Other Systems

1 Artificial Pancreas Devices Systems Market Overview
1.1 Product Definition
1.2 Artificial Pancreas Devices Systems by Type
1.2.1 Global Artificial Pancreas Devices Systems Market Value by Type: 2025 vs 2032
1.2.2 Threshold Suspended Device Systems
1.2.3 Hybrid Closed-loop APDS
1.2.4 Other Systems
1.3 Artificial Pancreas Devices Systems by Application
1.3.1 Global Artificial Pancreas Devices Systems Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Artificial Pancreas Devices Systems Market Size Estimates and Forecasts
1.4.1 Global Artificial Pancreas Devices Systems Revenue 2021–2032
1.4.2 Global Artificial Pancreas Devices Systems Sales 2021–2032
1.4.3 Global Artificial Pancreas Devices Systems Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Artificial Pancreas Devices Systems Market Competition by Manufacturers
2.1 Global Artificial Pancreas Devices Systems Sales Market Share by Manufacturers (2021–2026)
2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Artificial Pancreas Devices Systems Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Artificial Pancreas Devices Systems, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Artificial Pancreas Devices Systems, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Artificial Pancreas Devices Systems, Product Types and Applications
2.7 Global Key Manufacturers of Artificial Pancreas Devices Systems, Date of Entry into the Industry
2.8 Global Artificial Pancreas Devices Systems Market Competitive Situation and Trends
2.8.1 Global Artificial Pancreas Devices Systems Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Artificial Pancreas Devices Systems Players Market Share by Revenue
2.8.3 Global Artificial Pancreas Devices Systems Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Artificial Pancreas Devices Systems Market Scenario by Region
3.1 Global Artificial Pancreas Devices Systems Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Artificial Pancreas Devices Systems Sales by Region: 2021–2032
3.2.1 Global Artificial Pancreas Devices Systems Sales by Region: 2021–2026
3.2.2 Global Artificial Pancreas Devices Systems Sales by Region: 2027–2032
3.3 Global Artificial Pancreas Devices Systems Revenue by Region: 2021–2032
3.3.1 Global Artificial Pancreas Devices Systems Revenue by Region: 2021–2026
3.3.2 Global Artificial Pancreas Devices Systems Revenue by Region: 2027–2032
3.4 North America Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.4.1 North America Artificial Pancreas Devices Systems Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Artificial Pancreas Devices Systems Sales by Country (2021–2032)
3.4.3 North America Artificial Pancreas Devices Systems Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.5.1 Europe Artificial Pancreas Devices Systems Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Artificial Pancreas Devices Systems Sales by Country (2021–2032)
3.5.3 Europe Artificial Pancreas Devices Systems Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Pancreas Devices Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Artificial Pancreas Devices Systems Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Artificial Pancreas Devices Systems Sales by Region (2021–2032)
3.6.3 Asia Pacific Artificial Pancreas Devices Systems Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.7.1 Latin America Artificial Pancreas Devices Systems Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Artificial Pancreas Devices Systems Sales by Country (2021–2032)
3.7.3 Latin America Artificial Pancreas Devices Systems Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Pancreas Devices Systems Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country (2021–2032)
3.8.3 Middle East and Africa Artificial Pancreas Devices Systems Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Artificial Pancreas Devices Systems Sales by Type (2021–2032)
4.1.1 Global Artificial Pancreas Devices Systems Sales by Type (2021–2026)
4.1.2 Global Artificial Pancreas Devices Systems Sales by Type (2027–2032)
4.1.3 Global Artificial Pancreas Devices Systems Sales Market Share by Type (2021–2032)
4.2 Global Artificial Pancreas Devices Systems Revenue by Type (2021–2032)
4.2.1 Global Artificial Pancreas Devices Systems Revenue by Type (2021–2026)
4.2.2 Global Artificial Pancreas Devices Systems Revenue by Type (2027–2032)
4.2.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Type (2021–2032)
4.3 Global Artificial Pancreas Devices Systems Price by Type (2021–2032)
5 Segment by Application
5.1 Global Artificial Pancreas Devices Systems Sales by Application (2021–2032)
5.1.1 Global Artificial Pancreas Devices Systems Sales by Application (2021–2026)
5.1.2 Global Artificial Pancreas Devices Systems Sales by Application (2027–2032)
5.1.3 Global Artificial Pancreas Devices Systems Sales Market Share by Application (2021–2032)
5.2 Global Artificial Pancreas Devices Systems Revenue by Application (2021–2032)
5.2.1 Global Artificial Pancreas Devices Systems Revenue by Application (2021–2026)
5.2.2 Global Artificial Pancreas Devices Systems Revenue by Application (2027–2032)
5.2.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Application (2021–2032)
5.3 Global Artificial Pancreas Devices Systems Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Bigfoot Biomedical
6.2.1 Bigfoot Biomedical Company Information
6.2.2 Bigfoot Biomedical Description and Business Overview
6.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
6.2.5 Bigfoot Biomedical Recent Developments/Updates
6.3 Beta Bionics
6.3.1 Beta Bionics Company Information
6.3.2 Beta Bionics Description and Business Overview
6.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
6.3.5 Beta Bionics Recent Developments/Updates
6.4 Admetsys
6.4.1 Admetsys Company Information
6.4.2 Admetsys Description and Business Overview
6.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
6.4.5 Admetsys Recent Developments/Updates
6.5 Insulet
6.5.1 Insulet Company Information
6.5.2 Insulet Description and Business Overview
6.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
6.5.5 Insulet Recent Developments/Updates
6.6 Tandem Diabetes Care
6.6.1 Tandem Diabetes Care Company Information
6.6.2 Tandem Diabetes Care Description and Business Overview
6.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
6.6.5 Tandem Diabetes Care Recent Developments/Updates
6.7 Defymed
6.7.1 Defymed Company Information
6.7.2 Defymed Description and Business Overview
6.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
6.7.5 Defymed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Pancreas Devices Systems Industry Chain Analysis
7.2 Artificial Pancreas Devices Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Pancreas Devices Systems Production Mode & Process Analysis
7.4 Artificial Pancreas Devices Systems Sales and Marketing
7.4.1 Artificial Pancreas Devices Systems Sales Channels
7.4.2 Artificial Pancreas Devices Systems Distributors
7.5 Artificial Pancreas Devices Systems Customer Analysis
8 Artificial Pancreas Devices Systems Market Dynamics
8.1 Artificial Pancreas Devices Systems Industry Trends
8.2 Artificial Pancreas Devices Systems Market Drivers
8.3 Artificial Pancreas Devices Systems Market Challenges
8.4 Artificial Pancreas Devices Systems Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Artificial Pancreas Devices Systems Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Artificial Pancreas Devices Systems Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Artificial Pancreas Devices Systems Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Artificial Pancreas Devices Systems Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Artificial Pancreas Devices Systems Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Artificial Pancreas Devices Systems Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Artificial Pancreas Devices Systems Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Artificial Pancreas Devices Systems Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Artificial Pancreas Devices Systems, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Artificial Pancreas Devices Systems, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Artificial Pancreas Devices Systems, Product Types and Applications
 Table 12. Global Key Manufacturers of Artificial Pancreas Devices Systems, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Artificial Pancreas Devices Systems Companies by Tier (Tier 1, Tier 2, Tier 3), based on Artificial Pancreas Devices Systems Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Artificial Pancreas Devices Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Artificial Pancreas Devices Systems Sales by Region (Units), 2021–2026
 Table 18. Global Artificial Pancreas Devices Systems Sales Market Share by Region (2021–2026)
 Table 19. Global Artificial Pancreas Devices Systems Sales by Region (Units), 2027–2032
 Table 20. Global Artificial Pancreas Devices Systems Sales Market Share by Region (2027–2032)
 Table 21. Global Artificial Pancreas Devices Systems Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Artificial Pancreas Devices Systems Revenue Market Share by Region (2021–2026)
 Table 23. Global Artificial Pancreas Devices Systems Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Artificial Pancreas Devices Systems Revenue Market Share by Region (2027–2032)
 Table 25. North America Artificial Pancreas Devices Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Artificial Pancreas Devices Systems Sales by Country (Units), 2021–2026
 Table 27. North America Artificial Pancreas Devices Systems Sales by Country (Units), 2027–2032
 Table 28. North America Artificial Pancreas Devices Systems Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Artificial Pancreas Devices Systems Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Artificial Pancreas Devices Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Artificial Pancreas Devices Systems Sales by Country (Units), 2021–2026
 Table 32. Europe Artificial Pancreas Devices Systems Sales by Country (Units), 2027–2032
 Table 33. Europe Artificial Pancreas Devices Systems Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Artificial Pancreas Devices Systems Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Artificial Pancreas Devices Systems Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Artificial Pancreas Devices Systems Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Artificial Pancreas Devices Systems Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Artificial Pancreas Devices Systems Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Artificial Pancreas Devices Systems Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Artificial Pancreas Devices Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Artificial Pancreas Devices Systems Sales by Country (Units), 2021–2026
 Table 42. Latin America Artificial Pancreas Devices Systems Sales by Country (Units), 2027–2032
 Table 43. Latin America Artificial Pancreas Devices Systems Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Artificial Pancreas Devices Systems Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Artificial Pancreas Devices Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Artificial Pancreas Devices Systems Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Artificial Pancreas Devices Systems Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Artificial Pancreas Devices Systems Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Artificial Pancreas Devices Systems Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Artificial Pancreas Devices Systems Sales (Units) by Type (2021–2026)
 Table 51. Global Artificial Pancreas Devices Systems Sales (Units) by Type (2027–2032)
 Table 52. Global Artificial Pancreas Devices Systems Sales Market Share by Type (2021–2026)
 Table 53. Global Artificial Pancreas Devices Systems Sales Market Share by Type (2027–2032)
 Table 54. Global Artificial Pancreas Devices Systems Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Artificial Pancreas Devices Systems Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Artificial Pancreas Devices Systems Revenue Market Share by Type (2021–2026)
 Table 57. Global Artificial Pancreas Devices Systems Revenue Market Share by Type (2027–2032)
 Table 58. Global Artificial Pancreas Devices Systems Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Artificial Pancreas Devices Systems Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Artificial Pancreas Devices Systems Sales (Units) by Application (2021–2026)
 Table 61. Global Artificial Pancreas Devices Systems Sales (Units) by Application (2027–2032)
 Table 62. Global Artificial Pancreas Devices Systems Sales Market Share by Application (2021–2026)
 Table 63. Global Artificial Pancreas Devices Systems Sales Market Share by Application (2027–2032)
 Table 64. Global Artificial Pancreas Devices Systems Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Artificial Pancreas Devices Systems Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Artificial Pancreas Devices Systems Revenue Market Share by Application (2021–2026)
 Table 67. Global Artificial Pancreas Devices Systems Revenue Market Share by Application (2027–2032)
 Table 68. Global Artificial Pancreas Devices Systems Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Artificial Pancreas Devices Systems Price (USD/Unit) by Application (2027–2032)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Medtronic Artificial Pancreas Devices Systems Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. Bigfoot Biomedical Company Information
 Table 76. Bigfoot Biomedical Description and Business Overview
 Table 77. Bigfoot Biomedical Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Bigfoot Biomedical Artificial Pancreas Devices Systems Product
 Table 79. Bigfoot Biomedical Recent Developments/Updates
 Table 80. Beta Bionics Company Information
 Table 81. Beta Bionics Description and Business Overview
 Table 82. Beta Bionics Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Beta Bionics Artificial Pancreas Devices Systems Product
 Table 84. Beta Bionics Recent Developments/Updates
 Table 85. Admetsys Company Information
 Table 86. Admetsys Description and Business Overview
 Table 87. Admetsys Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Admetsys Artificial Pancreas Devices Systems Product
 Table 89. Admetsys Recent Developments/Updates
 Table 90. Insulet Company Information
 Table 91. Insulet Description and Business Overview
 Table 92. Insulet Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Insulet Artificial Pancreas Devices Systems Product
 Table 94. Insulet Recent Developments/Updates
 Table 95. Tandem Diabetes Care Company Information
 Table 96. Tandem Diabetes Care Description and Business Overview
 Table 97. Tandem Diabetes Care Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Tandem Diabetes Care Artificial Pancreas Devices Systems Product
 Table 99. Tandem Diabetes Care Recent Developments/Updates
 Table 100. Defymed Company Information
 Table 101. Defymed Description and Business Overview
 Table 102. Defymed Artificial Pancreas Devices Systems Sales (Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Defymed Artificial Pancreas Devices Systems Product
 Table 104. Defymed Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Artificial Pancreas Devices Systems Distributors List
 Table 108. Artificial Pancreas Devices Systems Customers List
 Table 109. Artificial Pancreas Devices Systems Market Trends
 Table 110. Artificial Pancreas Devices Systems Market Drivers
 Table 111. Artificial Pancreas Devices Systems Market Challenges
 Table 112. Artificial Pancreas Devices Systems Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Artificial Pancreas Devices Systems
 Figure 2. Global Artificial Pancreas Devices Systems Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Artificial Pancreas Devices Systems Market Share by Type: 2025 & 2032
 Figure 4. Threshold Suspended Device Systems Product Picture
 Figure 5. Hybrid Closed-loop APDS Product Picture
 Figure 6. Other Systems Product Picture
 Figure 7. Global Artificial Pancreas Devices Systems Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Artificial Pancreas Devices Systems Market Share by Application: 2025 & 2032
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Global Artificial Pancreas Devices Systems Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Artificial Pancreas Devices Systems Market Size (US$ Million), 2021–2032
 Figure 13. Global Artificial Pancreas Devices Systems Sales (Units), 2021–2032
 Figure 14. Global Artificial Pancreas Devices Systems Average Price (USD/Unit), 2021–2032
 Figure 15. Artificial Pancreas Devices Systems Report Years Considered
 Figure 16. Artificial Pancreas Devices Systems Sales Share by Manufacturers in 2025
 Figure 17. Global Artificial Pancreas Devices Systems Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Artificial Pancreas Devices Systems Players: Market Share by Revenue in Artificial Pancreas Devices Systems in 2025
 Figure 19. Artificial Pancreas Devices Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Artificial Pancreas Devices Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Artificial Pancreas Devices Systems Sales Market Share by Country (2021–2032)
 Figure 22. North America Artificial Pancreas Devices Systems Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Artificial Pancreas Devices Systems Sales Market Share by Country (2021–2032)
 Figure 26. Europe Artificial Pancreas Devices Systems Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Artificial Pancreas Devices Systems Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Artificial Pancreas Devices Systems Revenue Market Share by Region (2021–2032)
 Figure 34. China Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Artificial Pancreas Devices Systems Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Artificial Pancreas Devices Systems Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Artificial Pancreas Devices Systems Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Artificial Pancreas Devices Systems Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. U.A.E Artificial Pancreas Devices Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Artificial Pancreas Devices Systems by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Artificial Pancreas Devices Systems by Type (2021–2032)
 Figure 56. Global Artificial Pancreas Devices Systems Price (USD/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Artificial Pancreas Devices Systems by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Artificial Pancreas Devices Systems by Application (2021–2032)
 Figure 59. Global Artificial Pancreas Devices Systems Price (USD/Unit) by Application (2021–2032)
 Figure 60. Artificial Pancreas Devices Systems Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc